BERLIN—Barley beta-glucan reduces serum lipid
levels, according to research presented in April at the First International
Congress on Pre-Diabetes and Metabolic Syndrome.
In the six-week study, 76 men and 79 women with
hypercholesterolemia, aged
25 to 73, completed a four-week low fat diet
prior to baseline. At the beginning of the trial, test subjects were randomly
allocated to one of four treatment groups or a control group and assayed for
blood lipids and other cardiovascular disease (CVD) bio markers. During the
course of the study, test groups were administered 3 g and 5 g doses of low
molecular weight (LMW) or high molecular weight (HMW) barley beta-glucan (from
Cargill) twice daily, in cereal and juice.
Post treatment assessment of blood lipids and
other CVD biomarkers revealed improvements in low-density lipoprotein (LDL)
cholesterol, triglycerides, markers of glycemic control
(glycosylated hemoglobin, HOMA model) and a key
marker of inflammation
(hs-CRP).
The researchers concluded both doses of LMW and
HMW barley beta-glucan improved blood lipids over a six-week treatment period.
For more information visit:
http://www.optimumdiabetics.com/?aid=983056
0 comments:
Post a Comment